April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
Tesla Is An AI Company That The Market Won’t Reward For Now
Amazon: The Margin Train Is Gaining Speed
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Arcellx, Inc. (ACLX) Stock Forecast for 2028. Aclx Prediction
Updated: April 24, 2024 (12:41)
Sector: HealthcareThe share price of Arcellx, Inc. (ACLX) now
50/200 Day Moving Average: $64.68 / $48.64
This figure corresponds to the Average Price over the previous 50/200 days. For Arcellx stocks, the 50-day moving average is the resistance level today.
For Arcellx stocks, the 200-day moving average is the resistance level today.
Are you interested in Arcellx, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arcellx stock price in 2028. How much will one Arcellx share be worth in 2028? Is it worth taking profit / loss on ACLX stock now or waiting? What are analysts' forecasts for Arcellx stock?
We forecast Arcellx stock performance using neural networks based on historical data on ACLX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Arcellx, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Arcellx analysts is $80.31. Today 200 Day Moving Average is the support level (48.64 $). 50 Day Moving Average is the resistance level (64.68 $).
Historical and forecast chart of Arcellx, Inc. stock
The chart below shows the historical price of Arcellx stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ACLX stock price can be found in the table below.
Unlocking the Future of Investing: A Deep Dive into ACLX Stock Projections for 2028
In the rapidly evolving pharmaceutical landscape, Arcellx, Inc. stands out as a beacon of innovative therapy solutions, particularly in the adaptive immune cell therapies arena. The question on every investor’s mind, however, is about the future of ACLX stock. As 2028 approaches, the financial community buzzes with queries: Is ACLX a good stock to buy? What does the ACLX stock forecast look like, and most importantly, can the ACLX stock price prediction for 2028 be made with any degree of certainty?
Forecasting Challenges and Factors Influencing ACLX Stock in 2028
Forecasting the trajectory of a development-stage company like Arcellx, especially its stock performance, comes with inherent challenges. Such predictions require a nuanced understanding of both the biotech industry and broader market forces. Factors such as regulatory approvals, market adoption of its therapies, competition, and general economic conditions will play pivotal roles in shaping the ACLX stock price target for 2028.
Given the company’s innovative approach to cancer treatments—that can be silenced, activated, and reprogrammed according to disease progression—significant breakthroughs or setbacks in clinical trials could dramatically influence investor sentiment. Thus, determining whether to buy or sell Arcellx stock hinges on closely monitoring these developments.
The ACLX stock forecast, including its price prediction, is subject to high variability. However, should Arcellx continue to advance its pipeline products and secure regulatory endorsements, the company could emerge as a strong performer in the biotech sector. That said, external factors, including healthcare policy changes and economic shifts, could impact the Arcellx name stock forecast for 2028.
Investors pondering over “ACLX stock buy or sell” or “why ACLX stock down” moments must stay attuned to both the company’s scientific progress and the broader market dynamics. Predicting stock rates with pinpoint accuracy may be challenging, but astute investors will keep a keen eye on Arcellx’s potential to revolutionize cancer treatment.
In conclusion, while the ACLX stock price prediction for 2028 might not be crystal clear, the company’s focus on cutting-edge cancer therapies makes it a notable contender in the biotech arena. Investors should weigh the risks and opportunities, keeping an eye on the many factors that could influence the Arcellx stock forecast and decide if it aligns with their investment strategy.
Arcellx (ACLX) Forecast for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 50.88 | 48.70 | 56.11 | 13.20 % |
| Feb | 51.08 | 48.03 | 53.94 | 10.96 % |
| Mar | 53.60 | 49.84 | 58.48 | 14.78 % |
| Apr | 56.11 | 53.05 | 58.88 | 9.91 % |
| May | 53.41 | 48.34 | 56.05 | 13.75 % |
| Jun | 55.08 | 52.29 | 59.73 | 12.47 % |
| Jul | 60.02 | 53.86 | 66.11 | 18.53 % |
| Aug | 57.76 | 54.30 | 63.31 | 14.23 % |
| Sep | 60.31 | 55.92 | 65.64 | 14.81 % |
| Oct | 64.15 | 62.40 | 67.15 | 7.08 % |
| Nov | 66.15 | 61.08 | 68.99 | 11.47 % |
| Dec | 67.79 | 62.24 | 73.60 | 15.44 % |
Arcellx information and performance
25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD, US
Market capitalization of the Arcellx, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ACLX shares in the company outstanding by the market price of one share.
EBITDA of Arcellx is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Arcellx price target for 2028 by month
Target values for the price of one Arcellx share for Jan 2028.
In Jan, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 13.204% volatility is expected.
Pessimistic target level: 48.70
Optimistic target level: 56.11
Target values for the price of one Arcellx share for Feb 2028.
In Feb, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 10.957% volatility is expected.
Pessimistic target level: 48.03
Optimistic target level: 53.94
Target values for the price of one Arcellx share for Mar 2028.
In Mar, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 14.775% volatility is expected.
Pessimistic target level: 49.84
Optimistic target level: 58.48
Target values for the price of one Arcellx share for Apr 2028.
In Apr, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 9.910% volatility is expected.
Pessimistic target level: 53.05
Optimistic target level: 58.88
Target values for the price of one Arcellx share for May 2028.
In May, the Negative dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 13.751% volatility is expected.
Pessimistic target level: 48.34
Optimistic target level: 56.05
Target values for the price of one Arcellx share for Jun 2028.
In Jun, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 12.467% volatility is expected.
Pessimistic target level: 52.29
Optimistic target level: 59.73
Target values for the price of one Arcellx share for Jul 2028.
In Jul, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 18.531% volatility is expected.
Pessimistic target level: 53.86
Optimistic target level: 66.11
Target values for the price of one Arcellx share for Aug 2028.
In Aug, the Negative dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 14.231% volatility is expected.
Pessimistic target level: 54.30
Optimistic target level: 63.31
Target values for the price of one Arcellx share for Sep 2028.
In Sep, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 14.811% volatility is expected.
Pessimistic target level: 55.92
Optimistic target level: 65.64
Target values for the price of one Arcellx share for Oct 2028.
In Oct, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 7.079% volatility is expected.
Pessimistic target level: 62.40
Optimistic target level: 67.15
Target values for the price of one Arcellx share for Nov 2028.
In Nov, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 11.468% volatility is expected.
Pessimistic target level: 61.08
Optimistic target level: 68.99
Target values for the price of one Arcellx share for Dec 2028.
In Dec, the Positive dynamics for Arcellx, Inc. shares will prevail with possible monthly volatility of 15.445% volatility is expected.
Pessimistic target level: 62.24
Optimistic target level: 73.60
